Skip to main content
DIACEUTICS PLC logo

DIACEUTICS PLC — Investor Relations & Filings

Ticker · DXRX ISIN · GB00BJQTGV64 LEI · 213800VEWQBB39ZB8J81 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 277 across all filing types
Latest filing 2024-07-01 Director's Dealing
Country GB United Kingdom
Listing IL DXRX

About DIACEUTICS PLC

https://www.diaceutics.com/

Diaceutics PLC is a data analytics and end-to-end services provider focused on the development and commercialization of precision medicine diagnostics. The company supports pharmaceutical and biotech clients by providing solutions to improve the diagnostic testing ecosystem, aiming to ensure patients receive the correct personalized treatment. Its primary offering is DXRX, The Diagnostic Network®, a diagnostic commercialization platform for precision medicine. DXRX facilitates collaboration among stakeholders, including laboratories and pharmaceutical companies, in a secure marketplace and provides access to real-world diagnostic testing data. This integrated platform is designed to streamline the launch and adoption of new precision medicines.

Recent filings

Filing Released Lang Actions
PDMR Shareholding/SIP and Total Voting Rights
Director's Dealing Classification · 100% confidence The document is a regulatory notification filed via RNS (RNS Number : 4416U) on 01 July 2024. The content explicitly details share transactions (purchases and matched awards) by Persons Discharging Managerial Responsibilities (PDMRs) under Share Incentive Plans (SIP Schemes). This type of filing, which reports personal share transactions by directors and executives, directly corresponds to the definition of 'Director's Dealing'. The presence of the table structure titled 'Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014' confirms this is an insider transaction disclosure.
2024-07-01 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states in the title and body that it is the 'Result of Annual General Meeting' and details the outcome of all resolutions voted upon at the AGM, including proxy vote breakdowns. This directly corresponds to the definition of AGM Information (AGM-R). Although it contains voting results (DVA), the primary context is the formal announcement following the AGM event itself, making AGM-R the most precise fit. It is not a general regulatory filing (RNS) because it is highly specific to the AGM results.
2024-06-24 English
"Precision Medicine in Oncology " Virtual Event
Regulatory Filings Classification · 98% confidence The document is a press release distributed via RNS (Regulatory News Service), indicated by the 'RNS Number' header and the concluding boilerplate text mentioning 'Reach' and 'RNS, part of the London Stock Exchange'. The content announces an upcoming virtual event ('Precision Medicine in Oncology') hosted by Diaceutics PLC in collaboration with Labroots. This is not a formal financial report (like 10-K or IR), nor is it a transcript (CT) or a specific regulatory filing like a Director's Dealing (DIRS) or a Dividend Notice (DIV). It is a general announcement about a corporate activity (an event) released through the regulatory news wire. Since it is a general announcement distributed via RNS that doesn't fit the more specific categories like ER, CAP, or MANG, the most appropriate classification is the general Regulatory Filings category (RNS), which often serves as a catch-all for such news releases.
2024-06-13 English
Group of companies' accounts made up to 2023-12-31
Regulatory Filings
2024-06-10 English
Diaceutics - Capital Markets Event
Report Publication Announcement Classification · 99% confidence The document is a short announcement (2986 characters) published via RNS (RNS Number: 2891R) on June 6, 2024. The content explicitly announces a future 'Capital Markets Event' scheduled for June 12, 2024, detailing the purpose (deeper insight into the DXRX platform) and providing registration links. This is not a full financial report (like 10-K or IR) but rather an announcement about an upcoming investor/analyst event. Since it is an announcement about an event aimed at investors, it most closely aligns with Investor Presentation (IP) materials or a general announcement. However, given the nature of announcing a specific event for investors/analysts, it functions similarly to an Investor Presentation announcement, but the core action is announcing the event itself. Since there is no specific category for 'Capital Markets Event Announcement', and it is a formal regulatory filing announcement (RNS), I must check the definitions. It is not a proxy (PSI), dividend (DIV), or earnings release (ER). It is an announcement about an event that will likely feature presentation materials. Given the short length and the focus on announcing an event rather than providing the full presentation, it fits best as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if the event content is the focus. Since the document is primarily an announcement of an event and uses the RNS distribution mechanism, RNS is a strong candidate. However, the content is highly specific to investor relations regarding a future presentation/insight session. If we consider the closest fit for an event announcement that precedes the actual presentation materials, 'Investor Presentation' (IP) might be intended if the event itself is the primary focus. Given the structure and the RNS footer, classifying it as RNS (Regulatory Filings) is the safest fallback for a specific announcement that doesn't fit the core report types. But since it is specifically about an event where presentations will be given, and it's not a standard earnings call transcript (CT), I will lean towards the most specific category related to investor engagement, which is IP, or the general regulatory announcement RNS. Since it is an announcement *about* an event, and not the presentation itself, RNS is the most accurate classification based on Rule 2 (Menu vs Meal) for short announcements, unless the event type maps directly. Capital Markets Events often lead to IP materials. Given the context of announcing an event for analysts and investors, I will classify it as RNS as it is a formal regulatory announcement about a future event, fitting the general regulatory announcement category.
2024-06-06 English
Notice of AGM and Posting of Annual Report
Report Publication Announcement Classification · 100% confidence The document explicitly states: "Notice of AGM and Posting of Annual Report". It further clarifies that the company has "posted its Annual Report for the year ended 31 December 2023 to shareholders together with the Notice of the 2024 Annual General Meeting ("AGM")." The document itself is a short announcement (2788 characters) informing the market that these documents have been released and are available online. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report has been published or posted, without containing the full content of the report, should be classified as a Report Publication Announcement (RPA). While it mentions the AGM and Annual Report, the primary function of this specific filing is to announce the publication of those materials.
2024-05-29 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.